A new strain of the COVID-19 virus has been identified by a team of scientists at Texas A&M University Global Health Research Complex. The strain could prove to be more contagious and resistant to neutralizing antibodies.

Scientists who discovered the BV-1 variant — named after the Brazos Valley region where Texas A&M and the research center are located — said the mutation was found in only one person, but concerning the researchers was its similarities to the U.K. B.1.1.7 strain of COVID-19.

“We do not at present know the full significance of this variant, but it has a combination of mutations similar to other internationally notifiable variants of concern,” Global Health Research Complex Chief Virologist Ben Neuman said in a statement. “This variant combines genetic markers separately associated with rapid spread, severe disease and high resistance to neutralizing antibodies.”

The BV.1 mutation was detected via a saliva sample taken from a Texas A&M student as part of the university’s ongoing coronavirus testing program. The student’s test sample was positive for the virus on March 5.

The student, who resides off-campus, was given a second COVID test on March 25 that was also positive for the virus, which has led scientists to believe indicates that the BV-1 variant may have a longer infection period for adults aged 18 to 24.

On April 9, a third COVID test was given to the student, which was negative, showing no signs of the virus.

During the infection period, the student had mild, cold-like symptoms that never progressed, the researchers said.

While no other cases of the BV-1 variant have been found at this time, the scientists at GHRC have performed genetic sequence analysis in-lab on the sample and are watching closely for more student cases involving the BV-1 strain, giving its “potentially concerning genetic make-up.

According to the scientists at the Global Health Research Complex, it is performing genetic sequencing on asymptomatic students to find concerning mutations of COVID-19 before they can cause severe illnesses.

“Sequencing helps to provide an early warning system for new variants,” Neuman said. “Though we may not yet understand the full significance of BV-1, the variant highlights an ongoing need for rigorous surveillance and genomic testing, including among young adults with no symptoms or only mild symptoms.”

A paper on the BV-1 variant was submitted to the Centers for Disease Control and Prevention in Atlanta by the research team at the Global Health Research Complex.

Florida woman calls Walmart employees and shoppers cult members after they turned her away for not wearing a mask
Florida woman calls Walmart employees and shoppers cult members after they turned her away for not wearing a mask.jpg fernando zhiminaicela - Pixabay